Results 41 to 50 of about 206,217 (225)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response

open access: yesOncoImmunology, 2022
The immune system is recognized as an important factor in regulating the development, progression, and metastasis of cancer. Myeloid-derived suppressor cells (MDSCs) are a major immune-suppressive cell type by interfering with T cell activation ...
Takuya Kato   +9 more
doaj   +1 more source

Quickly evolving near‐infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment

open access: yesView, 2022
Among modalities of cancer immunotherapy, near‐infrared photoimmunotherapy (NIR‐PIT) has reached significant preclinical and clinical stages and quickly evolved over the last 5 years.
Hailey Monaco   +3 more
doaj   +1 more source

Trastuzumab‐based near‐infrared photoimmunotherapy in xenograft mouse of breast cancer

open access: yesCancer Medicine, 2023
Near‐infrared photoimmunotherapy (NIR‐PIT) is a novel form of cancer treatment using conjugates of antibody against overexpressed antigens in cancers and photoabsorber IRDye700DX.
Susumu Yamashita   +4 more
doaj   +1 more source

PIT - Produzieren im Takt

open access: yes, 2022
Zunehmend individuelle Kundenwünsche, schwankende Auftragsmengen und hohe Effizienzanforderungen verursachen besonders bei kleinen und mittleren Unternehmen einen hohen Aufwand.

core   +1 more source

Wound healing after excision of subcutaneous tumors treated with near‐infrared photoimmunotherapy

open access: yesCancer Medicine, 2020
Near‐infrared photoimmunotherapy (NIR‐PIT) is a novel cancer therapy that employs a combination of infrared light and tumor‐targeted monoclonal antibody‐photoabsorber conjugates to cause both direct tumor necrosis and immunogenic cell death.
Adrian Rosenberg   +7 more
doaj   +1 more source

Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT) [PDF]

open access: yesJournal of Controlled Release, 2016
Near infrared photoimmunotherapy (NIR-PIT), a targeted cancer therapy which uses an antibody-photo absorber conjugate (APC) and near infrared light exposure, dramatically improves nano-drug delivery into treated tumor beds due to enhanced vascular permeability.
Tadanobu, Nagaya   +5 more
openaire   +2 more sources

In vivo effect of NIR-PIT for MDAMB468 tumor (one shot NIR-PIT).

open access: yes, 2015
(A) NIR-PIT regimen. Fluorescence images were obtained at each time point as indicated. (B) In vivo fluorescence real-time imaging of tumor bearing mice in response to NIR-PIT.
Yuko Nakamura (645668)   +5 more
core   +1 more source

In vivo effect of NIR-PIT for MDAMB468 tumor (“three split” NIR-PIT).

open access: yes, 2015
(A) NIR-PIT regimen. (B) Tumor growth was significantly inhibited in the NIR-PIT treatment groups (n = 10–13, **p < 0.001 vs other groups, Bonferroni’s test with ANOVA). (C) Significantly prolonged survival was observed in the APC i.v. only group and NIR-
Yuko Nakamura (645668)   +5 more
core   +1 more source

Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor

open access: yesTranslational Oncology
Osteosarcoma is the most common bone tumor, and it possesses high metastatic propensity. Although systemic chemotherapy has improved its prognosis, improvements in survival rates have stalled in recent years.
Motofumi Suzuki   +2 more
doaj   +1 more source

Dynamically Actuated Reconfigurable Topographical Surface Enables Active Control of Implant‐Associated Infections

open access: yesAdvanced Functional Materials, EarlyView.
A dynamically actuated reconfigurable topographical surface (DARTS) integrates contact‐mediated bactericidal nanotopography with programmable mechanical actuation to actively disrupt bacterial biofilms. Dynamic surface reconfiguration enhances bacterial killing and suppresses implant‐associated infections in vivo, providing a new strategy for active ...
Mohammad Asadi Tokmedash   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy